CapsoVision Inc
capsovision.comWhat Do They Do?
Sells single-use capsule endoscopy systems and related software to gastroenterologists, clinics and hospitals to detect small-bowel abnormalities.
10-K for FY2025, filed Mar 26, 2026
How Do They Make Money?
The company sells capsules and capsule-reading devices, and provides video-reading and cloud-access services. It gets paid at or shortly after sale; capsule sales are tied to shipment, video-reading work to delivery of the finished video, and cloud access to a short service period after an upfront purchase.
10-K for FY2025, filed Mar 26, 2026The Company generates (i) product revenue from the sale of capsule medical devices, (ii) service revenue from the provision of reading…View ↗
The Company’s contracts with customers contain fixed consideration reflecting prices negotiated with customers and immaterial variable…View ↗
The Company does not have any significant financing components as payment is received at or shortly after sale. Standard trade credit terms…View ↗
Deferred revenue (contract liabilities, all of which are current in nature) consists of upfront purchases by customers related to the…View ↗
$13.6M
-
10-K for FY2025, filed Mar 26, 2026
$13.6M ↗
Who Are Their Customers?
In the U.S., gastroenterologists, clinics and hospitals buy mainly through the company’s direct sales team. Outside the U.S., distributors sell to customers in their markets, alongside the company’s direct sales.
10-K for FY2025, filed Mar 26, 2026We currently sell CapsoCam Plus capsules in the U.S. to our customers, which primarily include gastroenterologists practicing in clinics…View ↗
We primarily generate revenues from the sales of our CapsoCam Plus capsule to our customers, including gastroenterologists practicing in…View ↗
We operate with two sales groups and conduct our marketing strategies differently: one for the U.S. market and one for the international…View ↗
10-K for FY2025, filed Mar 26, 2026
The Company’s concentration risk related to revenues relates primarily to its product revenues being derived from a single product. With…View ↗
Do Revenues Turn Into Profits?
No. It lost $25.3M in FY2025.
10-K for FY2025, filed Mar 26, 2026
−$25.5MView ↗
10-K for FY2025, filed Mar 26, 2026
−$25.3MView ↗
10-K for FY2025, filed Mar 26, 2026
−$23MView ↗
How Are They Changing?
Who Do They Compete With?
Competes with Medtronic, IntroMedic, JinShan, and Ankon
10-K for FY2025, filed Mar 26, 2026CapsoCam Plus (small bowel). The competition that we face for our small bowel CapsoCam Plus is primarily from traditional enteroscopy…View ↗
Loading...
